ImmunoGen Reports Second Quarter Fiscal Year 2016 Financial Results and …

ImmunoGen Reports Second Quarter Fiscal Year 2016 Financial Results and …

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer therapeutics using its proprietary ADC technology, today reported financial results for the three-month period ended December 31, 2015 – the second quarter of …

(Visited 2 times, 1 visits today)
10
Like
Save

Comments

Comments are disabled for this post.